The RWD & RWE Podcast
*** Join our weekly Real-World Wednesdays (RWW) Clubhouse room every Wed @ 11am Eastern US Time*** All things related to the collection, creation & use of Real-World Data (RWD) in generating Real-World Evidence (RWE) for clinical research, drug development, medical devices, value access and other activities for BioPharma and the Life Sciences! Real-World Data (RWD): data relating to a person’s health status or well-being, or the care received by a person, as collected from real-world settings (as opposed to the controlled clinical trial setting) [aka observational data, healthcare data, etc.] Real-World Evidence (RWE): the appropriate analysis of RWD Reliable RWD + Appropriate Analysis = Meaningful RWE
Listen on:
Episodes
Friday May 26, 2023
Friday May 26, 2023
24 May 2023: 100th RWW: Conversation with David Thompson PhD, RWE thought-leader – We discussed his reflections on the market for RWD and RWE services, how it is simultaneously crowded and highly fragmented; the influence of regulatory agencies on RWE generation, both pro & con; the confluence of AI and RWE, and how these might combine to radically alter medical decision making at the point of care.
Thursday May 18, 2023
Thursday May 18, 2023
17 May 2023: Conversation with Leanne Larson, MHA, Principal at ZS Associates – We discussed the future of RWE - what will the Inflation Reduction Act (IRA) and FDA guidances on drug development mean for RWE?
Friday May 12, 2023
Friday May 12, 2023
10 May 2023: We’re at ISPOR and we discussed interesting things we saw/heard/learned. ISPOR attendees joined the discussion and provided their thoughts/insights
Sunday May 07, 2023
Sunday May 07, 2023
03 May 2023: Conversation with David Lindsay, MD, PhD, CEO of Oncora Medical – We discussed the use of public health real-world data and associated RWE use cases.
Wednesday Apr 26, 2023
Wednesday Apr 26, 2023
26 April 2023: Conversation with Andrea Thoumi MPP MSc and Kamaria Kaalund of the Duke-Margolis Center for Health Policy – We discussed the use of real-world data to inform community-engagement, diversity and inclusiveness across race and ethnicity.
Thursday Apr 20, 2023
Thursday Apr 20, 2023
19 April 2023: Conversation with Eirini Schlosser, Founder & CEO at Dyania Health – We discussed large language models (LLMs) — what are they, how are they used, what context is needed, availability, deployment — and the ROI of NLP turn healthcare inefficiencies into redundancies
Sunday Apr 16, 2023
Sunday Apr 16, 2023
12 April 2023: Conversation with Alex Vance MS, SVP Clinical Data Strategy & Operations at Holmusk – We discussed RWD’s role in behavioral healthcare and Life Science research.
Friday Apr 07, 2023
Friday Apr 07, 2023
05 April 2023: Conversation with Mauro Bucalo, CTO at Biomeris, – We discussed the health data systems in Italy and implementation of standards (e.g., i2b2 & OMOP) to support data analysis and clinical research across health systems.
Thursday Mar 30, 2023
Thursday Mar 30, 2023
29 March 2023: Conversation with Jacob Milliron PharmD MHA, Senior National Director, RWD & Solutions at Inovalon – We discussed social determinants of health (SDOH) RWD, specifically use cases where SDOH allows (or enhances) insights to assess and then improve health equity and research in underrepresented patient populations.
Thursday Mar 23, 2023
Thursday Mar 23, 2023
22 March 2023: Conversation with Charlie Barr MD MPH, Managing Director and Founder of Pivotal Strategic Consulting, and Sudhir Venkatesan PhD MPH, Director, Medical & Payer Evidence Statistics at AstraZeneca – We discussed considerations to appropriately match cohorts for real-world comparative analyses, including robust propensity score matching, negative controls, etc.